Wang Shu-Chiu, Tsai Liang-Miin, Chen Po-Ming, Hsu Yuan-Man, Wang Shu-Chen, Chang Chiung-Hung
Department of Traditional Chinese Medicine, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan, Taiwan, R.O.C.
Department of Internal Medicine, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan, Taiwan, R.O.C.
In Vivo. 2025 May-Jun;39(3):1625-1637. doi: 10.21873/invivo.13963.
BACKGROUND/AIM: While fertilization (IVF) is an effective treatment for infertility, the live birth rate remains suboptimal. This study aimed to evaluate the factors influencing live birth rates in infertile women undergoing a second round of IVF combined with traditional Chinese medicine (TCM) treatment.
This was a single-center, retrospective cohort study involving 45 infertile women undergoing a second round of IVF who underwent a combined treatment approach integrating TCM with IVF. Clinical factors affecting live birth rates were analyzed using Student's test, Pearson's Chi-square test, and univariate logistic regression models.
The findings revealed a clinical pregnancy rate of 51.11% and a live birth rate of 42.22%, underscoring the potential effectiveness of combining TCM with a second round of IVF for infertile women. Additionally, maternal age showed a statistically significant influence on the clinical pregnancy rate (39.32±2.93 years 36.48±2.47 years, =0.005) and live birth rate (39.68±2.85 years 35.58±2.95 years, <0.001).
Integrating traditional Chinese medicine into IVF protocols notably enhances maternal success rates. For women over 38, age-specific strategies such as fertility preservation, optimized ovarian stimulation, advanced embryo selection, and oocyte donation are key to addressing age-related challenges.
背景/目的:虽然体外受精(IVF)是治疗不孕症的有效方法,但活产率仍不尽人意。本研究旨在评估影响接受第二轮体外受精联合中医(TCM)治疗的不孕妇女活产率的因素。
这是一项单中心回顾性队列研究,纳入了45名接受第二轮体外受精的不孕妇女,她们采用了中医与体外受精相结合的联合治疗方法。使用学生检验、Pearson卡方检验和单因素逻辑回归模型分析影响活产率的临床因素。
研究结果显示临床妊娠率为51.11%,活产率为42.22%,这突出了中医与第二轮体外受精相结合对不孕妇女的潜在有效性。此外,产妇年龄对临床妊娠率(39.32±2.93岁对36.48±2.47岁,P=0.005)和活产率(39.68±2.85岁对35.58±2.95岁,P<0.001)有统计学显著影响。
将中医纳入体外受精方案可显著提高产妇成功率。对于38岁以上的女性,生育力保存、优化卵巢刺激、先进胚胎选择和卵母细胞捐赠等针对年龄的策略是应对与年龄相关挑战的关键。